LRFN2
Leucine-rich repeat and fibronectin type-III domain-containing protein 2
Also known as: FIGLER2, KIAA1246, LRFN2_HUMAN, SALM1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9ULH4
- Gene
- LRFN2
- Ensembl
- ENSG00000156564
- Chromosome
- 6
- Canonical length
- 789 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Predicted to be involved in modulation of chemical synaptic transmission and regulation of postsynapse organization. Predicted to be located in plasma membrane. Predicted to be active in several cellular components, including Schaffer collateral - CA1 synapse; cell surface; and postsynaptic density membrane. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
789 residues, UniProt reviewed canonical sequence.
>Q9ULH4|LRFN2
1 METLLGGLLA FGMAFAVVDA CPKYCVCQNL SESLGTLCPS KGLLFVPPDI DRRTVELRLG
61 GNFIIHISRQ DFANMTGLVD LTLSRNTISH IQPFSFLDLE SLRSLHLDSN RLPSLGEDTL
121 RGLVNLQHLI VNNNQLGGIA DEAFEDFLLT LEDLDLSYNN LHGLPWDSVR RMVNLHQLSL
181 DHNLLDHIAE GTFADLQKLA RLDLTSNRLQ KLPPDPIFAR SQASALTATP FAPPLSFSFG
241 GNPLHCNCEL LWLRRLERDD DLETCGSPGG LKGRYFWHVR EEEFVCEPPL ITQHTHKLLV
301 LEGQAATLKC KAIGDPSPLI HWVAPDDRLV GNSSRTAVYD NGTLDIFITT SQDSGAFTCI
361 AANAAGEATA MVEVSIVQLP HLSNSTSRTA PPKSRLSDIT GSSKTSRGGG GSGGGEPPKS
421 PPERAVLVSE VTTTSALVKW SVSKSAPRVK MYQLQYNCSD DEVLIYRMIP ASNKAFVVNN
481 LVSGTGYDLC VLAMWDDTAT TLTATNIVGC AQFFTKADYP QCQSMHSQIL GGTMILVIGG
541 IIVATLLVFI VILMVRYKVC NHEAPSKMAA AVSNVYSQTN GAQPPPPSSA PAGAPPQGPP
601 KVVVRNELLD FTASLARASD SSSSSSLGSG EAAGLGRAPW RIPPSAPRPK PSLDRLMGAF
661 ASLDLKSQRK EELLDSRTPA GRGAGTSARG HHSDREPLLG PPAARARSLL PLPLEGKAKR
721 SHSFDMGDFA AAAAGGVVPG GYSPPRKVSN IWTKRSLSVN GMLLPFEESD LVGARGTFGS
781 SEWVMESTVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LRFN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 6.3 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 6.3 nTPM
- amygdala: 2.9 nTPM
- retina: 2.9 nTPM
- hypothalamus: 2.6 nTPM
- hippocampal formation: 2.4 nTPM
- cerebellum: 2.3 nTPM
Single-cell type
- cone photoreceptor cells: 865 nCPM
- brain excitatory neurons: 97 nCPM
- rod photoreceptor cells: 91 nCPM
- oligodendrocyte progenitor cells: 87 nCPM
- retinal bipolar cells: 79 nCPM
- brain inhibitory neurons: 71 nCPM
Immune cell
- gdT-cell: 0.3 nTPM
- plasmacytoid DC: 0.2 nTPM
- naive CD4 T-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebral cortex: 41 nTPM
- white matter: 30 nTPM
- basal ganglia: 28 nTPM
- amygdala: 24 nTPM
- hippocampal formation: 21 nTPM
- thalamus: 18 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.71
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.6
- DepMap mean gene effect
- 0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Cysteine-rich flanking region, C-terminal
- Leucine-rich repeat
- Leucine-rich repeat, typical subtype
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Fibronectin type III
- Immunoglobulin-like domain
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Leucine-rich repeat domain superfamily
- Fibronectin type III superfamily
- Immunoglobulin-like domain superfamily
- Leucine-rich repeat and fibronectin type-III domain-containing
- Fibronectin type III domain
- Immunoglobulin I-set domain
- Leucine rich repeat
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LRFN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LRFN2 as an antibody target. Whether an autoantibody or antibody against LRFN2 could matter depends on whether native LRFN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LRFN2 is annotated at the cell surface, where native LRFN2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LRFN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...